Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Bally

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesM B Bally, R Nayar, D Masin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceM B Bally, D Masin, R Nayar, et al.
Cancer Research|February 1, 1990
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumorsL D Mayer, M B Bally, H Loughrey, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Anticancer Research|July 9, 2011
Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumorsM Verreault, D Strutt, D Masin, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsH J Lim, D Masin, N L McIntosh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivoS A Longman, P R Cullis, L Choi, et al.
Cancer Research|June 1, 1994
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumorsN L Boman, D Masin, L D Mayer, et al.
Anti-Cancer Drug Design|July 20, 2000
In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell linesS A Johnstone, K Gelmon, L D Mayer, et al.
British Journal of Cancer|October 1, 1995
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour modelsM S Webb, T O Harasym, D Masin, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1990
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesM B Bally, R Nayar, D Masin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceM B Bally, D Masin, R Nayar, et al.
Cancer Research|February 1, 1990
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumorsL D Mayer, M B Bally, H Loughrey, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Anticancer Research|July 9, 2011
Development of glioblastoma cell lines expressing red fluorescence for non-invasive live imaging of intracranial tumorsM Verreault, D Strutt, D Masin, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsH J Lim, D Masin, N L McIntosh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivoS A Longman, P R Cullis, L Choi, et al.
Cancer Research|June 1, 1994
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumorsN L Boman, D Masin, L D Mayer, et al.
Anti-Cancer Drug Design|July 20, 2000
In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell linesS A Johnstone, K Gelmon, L D Mayer, et al.
British Journal of Cancer|October 1, 1995
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour modelsM S Webb, T O Harasym, D Masin, et al.
Pageof 10